English
Alivus Life Sciences Q1 Results
- BSE: 543322
- NSE: ALIVUS
- ISIN: INE03Q201024
- Sector: Biotechnology & Drugs
BSE
874.55
-11.30 (-1.28%)
-11.30 (-1.28%)Volume1.35 K
Updated: Tue 13 Jan, 2026 | 15:24:05
NSE
875.50-12.15 (-1.37%)
-12.15 (-1.37%)Volume46.75 K
Updated: Tue 13 Jan, 2026 | 15:25:50
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Quarter ended Jun 25
Note: Comparison is on QoQ basis
Quarterly - Alivus Life Sciences Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 25 | Mar 25 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 446.60 | 467.08 | -4.39% | 443.52 | 0.69% |
| Depreciation/ Amortization | 17.06 | 15.97 | 6.85% | 14.39 | 18.61% |
| Operating Income | 155.25 | 182.46 | -14.92% | 145.10 | 6.99% |
| Net Income | 121.54 | 141.87 | -14.33% | 111.48 | 9.02% |
| Other Operating Expenses Total | 97.57 | 101.80 | -4.15% | 84.50 | 15.47% |
| Net Income Before Taxes | 162.98 | 191.29 | -14.80% | 150.24 | 8.48% |
| Total Revenue | 601.85 | 649.55 | -7.34% | 588.62 | 2.25% |
| Selling/ General/ Admin Expenses Total | 61.58 | 66.72 | -7.71% | 56.84 | 8.33% |
| Diluted Normalized EPS | 9.88 | 11.55 | -14.46% | 9.08 | 8.81% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.